secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001021771-23-000037
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative Therapies files accounting firm consents for S-3 registration statement
--------------------------------------------------------------------------------

- Filed consents of Friedman LLP and Marcum LLP to incorporate audit reports into Form S-3.
- Consents relate to reports dated March 30, 2022 and March 24, 2023 for 2022 Form 10-K.
- Purely administrative filing; no change in financial statements or business operations.
- No new financial results, guidance, or events disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000037/0001021771-23-000037-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000102177123000037/form8kdtd040623.htm
  HTML page:      https://secwatch.observer/filing/0001021771-23-000037

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer